Cargando…
Heart Fatty Acid Binding Protein and cardiac troponin: development of an optimal rule-out strategy for acute myocardial infarction
BACKGROUND: Improved ability to rapidly rule-out Acute Myocardial Infarction (AMI) in patients presenting with chest pain will promote decongestion of the Emergency Department (ED) and reduce unnecessary hospital admissions. We assessed a new commercial Heart Fatty Acid Binding Protein (H-FABP) assa...
Autores principales: | Young, Joanna M., Pickering, John W., George, Peter M., Aldous, Sally J., Wallace, John, Frampton, Chris M., Troughton, Richard W., Richards, Mark A., Greenslade, Jaimi H., Cullen, Louise, Than, Martin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006323/ https://www.ncbi.nlm.nih.gov/pubmed/27577952 http://dx.doi.org/10.1186/s12873-016-0089-y |
Ejemplares similares
-
Diagnostic and prognostic performance of the ratio between high-sensitivity cardiac troponin I and troponin T in patients with chest pain
por: Eggers, Kai M., et al.
Publicado: (2022) -
Assessment of the 2016 National Institute for Health and Care Excellence high-sensitivity troponin rule-out strategy
por: Carlton, Edward Watts, et al.
Publicado: (2018) -
Widespread Introduction of a High-Sensitivity Troponin Assay: Assessing the Impact on Patients and Health Services
por: Greenslade, Jaimi H., et al.
Publicado: (2020) -
Machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations
por: Doudesis, Dimitrios, et al.
Publicado: (2023) -
The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis
por: Jülicher, Paul, et al.
Publicado: (2017)